SCNX Return on Tangible Equity | SCIENTURE HOLDINGS, INC.

SCIENTURE HOLDINGS, INC. (SCNX) Return on Tangible Equity

2026-06-30: Return Tang Equity 138.83%.
2026-03-31: Return Tang Equity 166.92%.
2025-12-31: Return Tang Equity 186.78%.
2025-09-30: Return Tang Equity 136.09%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	138.83%
2026-03-31	166.92%
2025-12-31	186.78%
2025-09-30	136.09%
2025-06-30	101.10%
2025-03-31	91.78%
2024-12-31	-48.48%
2024-09-30	5.97%
2024-06-30	71.98%
2024-03-31	53.01%
2023-12-31	331.74%
2023-09-30	-125.97%
2023-06-30	195.59%
2023-03-31	2351.60%
2022-12-31	12147.61%
2022-09-30	-554.43%
2022-06-30	-404.60%
2022-03-31	-270.93%
2021-12-31	-141.00%
2021-09-30	-175.87%
2021-06-30	-106.77%
2021-03-31	-45.05%
2020-12-31	-31.89%
2020-09-30	-7.12%
2020-06-30	-8.81%
2020-03-31	-2.57%
2019-12-31	-8.33%
2019-09-30	0.72%
2019-06-30	14.57%
2019-03-31	10.57%
2018-12-31	7.61%
2018-09-30	103.49%
2018-06-30	-263.37%
2018-03-31	-151.67%
2017-12-31	-92.64%
2017-09-30	59.08%
2017-06-30	190.69%
2016-12-31	240.42%
2015-12-31	-418.39%
2015-09-30	-278.48%
2015-06-30	-287.71%
2015-03-31	-449.94%
2014-12-31	-301.01%
2014-09-30	-1409.47%
2014-06-30	3869.79%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	186.78%
2024-12-31	-48.48%
2023-12-31	7147.52%
2022-12-31	12029.17%
2021-12-31	-141.00%
2020-12-31	-31.89%
2019-12-31	-8.33%
2018-12-31	7.61%
2017-12-31	-92.64%
2016-12-31	240.42%
2015-12-31	-418.39%
2014-12-31	-301.01%
2013-12-31	-1598.05%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)	United States	$0.012B
Dare Bioscience, Inc. (DARE)	United States	$0.011B
BIOVIE INC. (BIVI)	United States	$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)	United States	$0.012B	-0.60
Tempest Therapeutics, Inc. (TPST)	United States	$0.013B
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33